a) is the product better than anything in its field? yes. b) is there global demand for the product? yes. c) How far away are revenues to justify the m.cap? 1 deal of around $5-10million per annum instanty justifies the $120m m.cap (at around a 30P/E ratio). d) whats the major barrier for the company for 2014? Getting one decent deal with a respected life science player .
now we know where thats at.
ADO Price at posting:
14.0¢ Sentiment: LT Buy Disclosure: Held
